China Launches Initiative for Belt and Road Partnership on COVID-19 Vaccine Cooperation with 28 Nations
Aug. 3, 2021 (EIRNS)—On June 23 of this year, at the Asia and Pacific High-Level Conference on Belt and Road Cooperation, presided over by State Councilor and Foreign Minister Wang Yi, 28 nations joined in launching the China Initiative for Belt and Road Partnership on COVID-19 Vaccine Cooperation. The statement announcing the initiative stressed that international cooperation and solidarity are key to fighting the pandemic, that “people and their lives” must be put first, and that no one is safe until everyone is safe. It emphasized that vaccines must be equitably distributed and that there must be “open, fair and non-discriminatory international cooperation on vaccines.”
A number of other recommendations for the BRI vaccine cooperation initiative included facilitating joint vaccine research, development and technological exchanges; promoting partnerships between vaccine producers and developing countries for joint vaccine production, to scale up global production; encouraging regional and multilateral development banks to provide more concessional financing to developing countries for their vaccine procurement and production; and “strengthening Belt and Road cooperation on connectivity to ensure cross-border flows of vaccines.”
According to the Chinese Foreign Ministry yesterday, in less than two months the BRI vaccine initiative has yielded impressive results, reaching cooperative agreements with several of the initiative’s 28 co-sponsors on a total of 775 million doses of vaccines, including in the form of concentrates, of which 350 million doses have been delivered. In addition, Chinese companies have started joint production with four co-sponsors of this initiative, whose names were not specified, and are discussing joint production “with other interested countries.” In today’s Foreign Ministry press conference, spokesman Wang Wenbin reported that Beijing has provided vaccine assistance to over 80 countries and vaccines to 40 countries, and furthermore that China is collaborating with other developing nations to mass produce the vaccine. It was also announced today that the World Health Organization has granted emergency use authorization to China’s Sinovac vaccine.
The 28 countries are: Afghanistan, Bangladesh, Brunei, Cambodia, Chile, China, Colombia, Fiji, Indonesia, Kazakhstan, Kyrgyzstan, Laos, Malaysia, Maldives, Mongolia, Myanmar, Nepal, Pakistan, the Philippines, Saudi Arabia, Singapore, Solomon Islands, Sri Lanka, Tajikistan, Thailand, Turkmenistan, United Arab Emirates, Uzbekistan, and Viet Nam.